The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients
Abstract
We conducted a placebo-controlled, double-blind study of acyclovir therapy for acute herpes zoster in immunocompromised patients. Of the 94 patients enrolled in the study, 52 had localized skin lesions at entry, and 42 had disseminated cutaneous zoster. A one-week course of intravenous acyclovir (1500 mg per square meter of body-surface area per day) halted progression of zoster in both groups, as determined by development or progression of cutaneous dissemination, development of visceral zoster, or proportion of cases deemed treatment failures. Significantly fewer patients treated with acyclovir within the first three days after the onset of exanthem had complications of zoster, as compared with patients treated with placebo (P = 0.02 by Fisher's exact test), but acyclovir also stopped progression of zoster in patients treated after three days of rash (P = 0.05 by Fisher's exact test). Acyclovir recipients with disseminated cutaneous zoster had a significantly accelerated rate of clearance of virus from vesicles, as compared with placebo recipients (P = 0.05 by the Breslow test).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer
Merigan, T. C., Rand, K. H., Pollard, R. B., Abdallah, P. S., Jordan, G. W., & Fried, R. P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805042981801 · Cited by 357
Herpes Zoster-Varicella Infections in Immunosuppressed Patients
DOLIN, R., REICHMAN, R. C., MAZUR, M. H., & WHITLEY, R. J. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-3-375 · Cited by 273
Herpes Zoster-Varicella Infections and Lymphoma
GOFFINET, D. R., GLATSTEIN, E. J., & MERIGAN, T. C. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-2-235 · Cited by 209
Cited by
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Self-citationArvin, A. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.361 · Cited by 1,162
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869
Weller, T. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092205 · Cited by 493
(1986) · The Lancet · doi:10.1016/s0140-6736(86)90889-5 · Cited by 465
Metadata
- Authors
- Balfour, H. H., Bean, B., Laskin, O. L., Ambinder, R. F., Meyers, J. D., Wade, J. C., Zaia, J. A., Aeppli, D., Kirk, L. E., Segreti, A. C., Keeney, R. E., & the Burroughs Wellcome Collaborative Acyclovir Study Group*
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1983-06-16
- Volume
- 308
- Issue
- 24
- Pages
- 1448-1453
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338795352
- Cited by
- 414
- References
- 4
- FWCI
- 38.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients. https://app.cochat.ai/papers/10.1056/nejm198306163082404
- The paper
- Balfour, H. H., Bean, B., Laskin, O. L., Ambinder, R. F., Meyers, J. D., Wade, J. C., Zaia, J. A., Aeppli, D., Kirk, L. E., Segreti, A. C., Keeney, R. E., & the Burroughs Wellcome Collaborative Acyclovir Study Group*. (1983). Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients. New England Journal of Medicine. https://doi.org/10.1056/nejm198306163082404
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.